{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:30:48Z","timestamp":1792096248315,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1038\/modpathol.2013.96","type":"journal-article","created":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T07:40:10Z","timestamp":1369381210000},"page":"1525-1535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":179,"title":["Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer"],"prefix":"10.1016","volume":"26","author":[{"given":"Tjalling","family":"Bosse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalja T","family":"ter Haar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M","family":"Seeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J v","family":"Diest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik J","family":"Hes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans FA","family":"Vasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi A","family":"Nout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carien L","family":"Creutzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Morreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent THBM","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2013.96_bib1","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1101\/gr.137596.112","article-title":"Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer","volume":"22","author":"Liang","year":"2012","journal-title":"Genome Res"},{"key":"10.1038\/modpathol.2013.96_bib2","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1158\/0008-5472.CAN-11-1562","article-title":"ARIDIA, a factor that promotes formation of SWI\/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers","volume":"71","author":"Guan","year":"2011","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.96_bib3","first-page":"642","article-title":"Loss of ARID1A\/BAF250a expression in ovarian endometriosis and clear cell carcinoma","volume":"5","author":"Xiao","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1038\/modpathol.2013.96_bib4","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.3390\/ijms11125120","article-title":"Clinicopathological significance of loss of ARID1A Immunoreactivity in ovarian clear cell carcinoma","volume":"11","author":"Maeda","year":"2010","journal-title":"Int J Mol Sci"},{"key":"10.1038\/modpathol.2013.96_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/PAP.0b013e31827bc24d","article-title":"Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms","volume":"20","author":"Maeda","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/modpathol.2013.96_bib6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/PAS.0b013e318212782a","article-title":"Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma","volume":"35","author":"Guan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.96_bib7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/path.2911","article-title":"Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas","volume":"224","author":"Wiegand","year":"2011","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2013.96_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.humpath.2012.04.021","article-title":"Clinicopathologic analysis of loss of AT-rich interactive domain 1A expression in endometrial cancer","volume":"44","author":"Rahman","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.96_bib9","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/onc.2009.4","article-title":"The SWI\/SNF complex and cancer","volume":"28","author":"Reisman","year":"2009","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2013.96_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrc3068","article-title":"SWI\/SNF nucleosome remodellers and cancer","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/modpathol.2013.96_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/2159-8290.CD-12-0361","article-title":"ARID1A mutations in cancer: another epigenetic tumor suppressor?","volume":"3","author":"Wu","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1038\/modpathol.2013.96_bib12","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ng.982","article-title":"Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer","volume":"43","author":"Wang","year":"2011","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2013.96_bib13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0b013e318202772e","article-title":"A proposed model for endometrial serous carcinogenesis","volume":"35","author":"Zheng","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.96_bib14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00428-012-1303-2","article-title":"ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein\u2013Barr virus infection and microsatellite instability","volume":"461","author":"Abe","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2013.96_bib15","doi-asserted-by":"crossref","first-page":"e40364","DOI":"10.1371\/journal.pone.0040364","article-title":"Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/modpathol.2013.96_bib16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/humu.21633","article-title":"Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types","volume":"33","author":"Jones","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1038\/modpathol.2013.96_bib17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1677\/ERC-10-0014","article-title":"Methylation profiles of endometrioid and serous endometrial cancers","volume":"17","author":"Seeber","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1038\/modpathol.2013.96_bib18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ygyno.2012.05.012","article-title":"Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt\/beta-catenin and P53 pathway activation","volume":"126","author":"Nout","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2013.96_bib19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH701>3.0.CO;2-2","article-title":"Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients","volume":"192","author":"de Leeuw","year":"2000","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2013.96_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1155\/2004\/391039","article-title":"Identification of HNPCC by molecular analysis of colorectal and endometrial tumors","volume":"20","author":"Vasen","year":"2004","journal-title":"Dis Markers"},{"key":"10.1038\/modpathol.2013.96_bib21","first-page":"1","article-title":"Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts","volume":"0","author":"Vasen","year":"2013","journal-title":"Gut"},{"key":"10.1038\/modpathol.2013.96_bib22","doi-asserted-by":"crossref","first-page":"e17791","DOI":"10.1371\/journal.pone.0017791","article-title":"Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR","volume":"6","author":"van","year":"2011","journal-title":"PLoS One"},{"key":"10.1038\/modpathol.2013.96_bib23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1471-2407-10-180","article-title":"Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?","volume":"10","author":"van Roon","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1038\/modpathol.2013.96_bib24","first-page":"5248","article-title":"A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer","volume":"58","author":"Boland","year":"1998","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.96_bib25","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/modpathol.2012.174","article-title":"ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas","volume":"26","author":"Werner","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.96_bib26","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2013.96_bib27","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/1066896909337600","article-title":"Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: a comparative analysis emphasizing the importance of distinguishing between these two groups","volume":"18","author":"Bartosch","year":"2010","journal-title":"Int J Surg Pathol"},{"key":"10.1038\/modpathol.2013.96_bib28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/jcp.2009.071225","article-title":"Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type","volume":"63","author":"Clarke","year":"2010","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2013.96_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4161\/epi.3.2.6153","article-title":"Involvement of the chromatin-remodeling factor BRG1\/SMARCA4 in human cancer","volume":"3","author":"Medina","year":"2008","journal-title":"Epigenetics"},{"key":"10.1038\/modpathol.2013.96_bib30","first-page":"560","article-title":"Loss of BRG1\/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis","volume":"63","author":"Reisman","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.96_bib31","first-page":"6171","article-title":"BRG1, a component of the SWI\u2013SNF complex, is mutated in multiple human tumor cell lines","volume":"60","author":"Wong","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.96_bib32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.humpath.2011.06.009","article-title":"Loss of expression of the SWI\/SNF chromatin remodeling subunit BRG1\/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas","volume":"43","author":"Dal","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.96_bib33","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/PAS.0b013e31822b325b","article-title":"INI1-deficient tumors: diagnostic features and molecular genetics","volume":"35","author":"Hollmann","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.96_bib34","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1073\/pnas.0801802105","article-title":"ES cell pluripotency and germ-layer formation require the SWI\/SNF chromatin remodeling component BAF250a","volume":"105","author":"Gao","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2013.96_bib35","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/modpathol.2011.189","article-title":"Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations","volume":"25","author":"Yamamoto","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.96_bib36","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.canep.2011.07.006","article-title":"Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance","volume":"36","author":"Zhang","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"10.1038\/modpathol.2013.96_bib37","doi-asserted-by":"crossref","first-page":"7518","DOI":"10.1158\/1078-0432.CCR-11-1664","article-title":"Targeting the mTOR\/4E-BP pathway in endometrial cancer","volume":"17","author":"Korets","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2013.96_bib38","doi-asserted-by":"crossref","first-page":"e53931","DOI":"10.1371\/journal.pone.0053931","article-title":"Promoter hypermethylation of ARID1A gene is responsible for its low mRNA rxpression in many invasive breast cancers","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/modpathol.2013.96_bib39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4161\/epi.5.6.12431","article-title":"DNA methylation in endometrial cancer","volume":"5","author":"Tao","year":"2010","journal-title":"Epigenetics"},{"key":"10.1038\/modpathol.2013.96_bib40","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.4161\/cc.20280","article-title":"Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors","volume":"11","author":"McKenna","year":"2012","journal-title":"Cell Cycle"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol201396.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201396","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222030289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222030289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201396.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:07:10Z","timestamp":1760231230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222030289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0893395222030289"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2013.96","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2013.96","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}